Drug Trial Radar · NCT06922045
Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients
Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
40
Actual
Start
Mar 26, 2025
Primary completion
Sep 2026
Study completion Mar 2027
Sponsor
- Lead sponsor
- Jiangsu BioJeTay Biotechnology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor
Conditions
- Hemophilia
Interventions
STSP-0601 for InjectionDrug
Evaluation of the Efficacy of Single-Dose and Continuous Administration of STSP-0601 Injection for the Treatment of Bleeding in Patients with Hemophilia A or B with Inhibitors
Primary outcomes
What the sponsor says the trial is designed to measure.
- 12 hours effective hemostasis rateTime frame: 12 hours after the first administration
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Anhui Provincial Hospital
Hefei, Anhui, China
Lanzhou University First Hospital
Lanzhou, Gansu, China
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
The First affiliated hospital of Guangxi Medical University
Nanning, Guangxi, China
North China University of Science and Technology Affiliated Hospital
Tangshan, Hebei, China
Harbin First Hospital Hematology Tumor Research Center
Harbin, Heilongjiang, China
Henan Cancer Hospital
Zhengzhou, Henan, China
Huazhong University of Science and Technology Union Hospital
Wuhan, Hubei, China
Jiangsu Provincial Hospital
Nanjing, Jiangsu, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Jinan Central Clinical College of Shandong First Medical University
Jinan, Shandong, China
Second hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Xi'an Central Hospital
Xi’an, Shanxi, China
Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Hospital of Hematology, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China
The Second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Wenzhou People's Hospital
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.